Ann‐Sofie Jemth
Impact in
- Molecular Biology top 5%
- DNA Repair Mechanisms
- Biochemical and Molecular Research
- DNA and Nucleic Acid Chemistry
- Oncology top 5%
- PARP inhibition in cancer therapy
Papers in
-
- Biochemical and Molecular Research 14
- DNA Repair Mechanisms 9
- Protein Structure and Dynamics 1
-
- Advanced Proteomics Techniques and Applications 2
- Co-authors
- Thomas Helleday (34 shared papers)Olga Loseva (13 shared papers)Helen E. Bryant (3 shared papers)Pål Stenmark (21 shared papers)Niklas Schultz (1 shared paper)Fredrik Johansson (1 shared paper)Serena Fernandez (1 shared paper)Peter McGlynn (1 shared paper)
- Journals
- Journal of Biological Chemistry (6 papers)Nature Communications (4 papers)Journal of Medicinal Chemistry (4 papers)FEBS Letters (3 papers)Cancer Research (3 papers)
- Partner nations
- SwedenUnited KingdomGermany
In The Last Decade
Ann‐Sofie Jemth
51 papers receiving 3.3k citations
Ann‐Sofie Jemth's Hit Papers
Peers
Comparison fields: 5 of 73
- Molecular Biology 1.1k
- Oncology 379
- Pharmacology 94
- Cancer Research 92
- Computational Theory and Mathematics 111
Countries citing papers authored by Ann‐Sofie Jemth
This map shows the geographic impact of Ann‐Sofie Jemth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann‐Sofie Jemth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann‐Sofie Jemth more than expected).
Fields of papers citing papers by Ann‐Sofie Jemth
This network shows the impact of papers produced by Ann‐Sofie Jemth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann‐Sofie Jemth. The network helps show where Ann‐Sofie Jemth may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann‐Sofie Jemth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 510 | |
| 2 | MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool Hit paper breakdown → | 2014 | 441 |
| 3 | Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy Hit paper breakdown → | 2014 | 344 |
| 4 | 2018 | 198 | |
| 5 | 2010 | 133 | |
| 6 | 2017 | 125 | |
| 7 | 2015 | 123 | |
| 8 | 2016 | 111 | |
| 9 | 2017 | 111 | |
| 10 | 2016 | 108 | |
| 11 | 2015 | 95 | |
| 12 | 2010 | 90 | |
| 13 | 2009 | 87 | |
| 14 | 2018 | 86 | |
| 15 | 2016 | 81 | |
| 16 | 2011 | 76 | |
| 17 | 2022 | 66 | |
| 18 | 2022 | 65 | |
| 19 | 2020 | 50 | |
| 20 | 2019 | 46 |
About Ann‐Sofie Jemth
Ann‐Sofie Jemth is a scholar working on Molecular Biology, Spectroscopy, Oncology, Pharmacology and Rheumatology, having authored 55 papers that have together received 3.4k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (14 papers), DNA Repair Mechanisms (9 papers), PARP inhibition in cancer therapy (2 papers), Advanced Proteomics Techniques and Applications (2 papers), Enzyme Structure and Function (2 papers), Folate and B Vitamins Research (1 paper), Pharmacogenetics and Drug Metabolism (1 paper) and Protein Structure and Dynamics (1 paper). The work is most often cited by research in Molecular Biology (1.1k citations), Oncology (379 citations), Pharmacology (94 citations), Cancer Research (92 citations) and Computational Theory and Mathematics (111 citations). Ann‐Sofie Jemth has collaborated with scholars based in Sweden, United Kingdom and Germany. Frequent co-authors include Thomas Helleday, Olga Loseva, Helen E. Bryant, Pål Stenmark, Niklas Schultz, Fredrik Johansson, Serena Fernandez, Peter McGlynn, Natalia Issaeva and Eva Petermann. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications, Journal of Medicinal Chemistry, FEBS Letters and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.